{"id":28944,"date":"2026-06-23T16:19:13","date_gmt":"2026-06-23T19:19:13","guid":{"rendered":"https:\/\/femama.org.br\/site\/?p=28944"},"modified":"2026-06-23T16:20:10","modified_gmt":"2026-06-23T19:20:10","slug":"novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/","title":{"rendered":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (22), o registro do medicamento <strong>Inluriyo\u00ae (tosilato de inlunestranto)<\/strong>, uma nova op\u00e7\u00e3o terap\u00eautica para pacientes adultas com c\u00e2ncer de mama localmente avan\u00e7ado ou metast\u00e1tico que j\u00e1 tenham realizado tratamento pr\u00e9vio com terapia end\u00f3crina. A informa\u00e7\u00e3o foi publicada nesta segunda-feira (22) no site da Anvisa.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A indica\u00e7\u00e3o contempla casos de tumores com receptor hormonal positivo (ER+), receptor HER2 negativo (HER2-) e presen\u00e7a de muta\u00e7\u00e3o no gene ESR1, perfil associado a determinados tipos de c\u00e2ncer de mama avan\u00e7ado e que pode influenciar na resposta ao tratamento ao longo da evolu\u00e7\u00e3o da doen\u00e7a.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Desenvolvido pela Eli Lilly do Brasil, o medicamento \u00e9 administrado por via oral e aprovado para uso em monoterapia, ampliando o cen\u00e1rio de inova\u00e7\u00e3o terap\u00eautica dispon\u00edvel para o cuidado oncol\u00f3gico.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">O c\u00e2ncer de mama \u00e9 o tipo de c\u00e2ncer mais incidente entre mulheres no Brasil. De acordo com a publica\u00e7\u00e3o Estimativa 2026\u20132028: Incid\u00eancia de C\u00e2ncer no Brasil, do Instituto Nacional de C\u00e2ncer (INCA), s\u00e3o esperados 78.610 novos casos anuais da doen\u00e7a no pa\u00eds durante o per\u00edodo, o que representa um risco estimado de 71,57 casos a cada 100 mil mulheres.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A aprova\u00e7\u00e3o foi publicada no Di\u00e1rio Oficial da Uni\u00e3o por meio da Resolu\u00e7\u00e3o n\u00ba 2.465\/2026 e amplia o conjunto de alternativas terap\u00eauticas dispon\u00edveis para pacientes que vivem com a doen\u00e7a, contribuindo para o avan\u00e7o do cuidado e para a amplia\u00e7\u00e3o das possibilidades de tratamento no cen\u00e1rio do c\u00e2ncer de mama avan\u00e7ado.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (22), o registro do medicamento Inluriyo\u00ae (tosilato de inlunestranto), uma nova op\u00e7\u00e3o terap\u00eautica para pacientes adultas com c\u00e2ncer de mama localmente avan\u00e7ado ou metast\u00e1tico que j\u00e1 tenham realizado tratamento pr\u00e9vio com terapia end\u00f3crina. A informa\u00e7\u00e3o foi publicada nesta segunda-feira (22) no site da Anvisa.\u00a0 A [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":28946,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13,1],"tags":[],"class_list":["post-28944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-recentes","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (22), o registro do medicamento Inluriyo\u00ae (tosilato de inlunestranto), uma nova op\u00e7\u00e3o terap\u00eautica para pacientes adultas com c\u00e2ncer de mama localmente avan\u00e7ado ou metast\u00e1tico que j\u00e1 tenham realizado tratamento pr\u00e9vio com terapia end\u00f3crina. A informa\u00e7\u00e3o foi publicada nesta segunda-feira (22) no site da Anvisa.\u00a0 A [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-23T19:19:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-23T19:20:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1140\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA\",\"datePublished\":\"2026-06-23T19:19:13+00:00\",\"dateModified\":\"2026-06-23T19:20:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/\"},\"wordCount\":293,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Capa-materia-17377-3.png\",\"articleSection\":[\"Not\u00edcias recentes\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/\",\"name\":\"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Capa-materia-17377-3.png\",\"datePublished\":\"2026-06-23T19:19:13+00:00\",\"dateModified\":\"2026-06-23T19:20:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Capa-materia-17377-3.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Capa-materia-17377-3.png\",\"width\":1140,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/sem-categoria\\\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/","og_locale":"pt_BR","og_type":"article","og_title":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (22), o registro do medicamento Inluriyo\u00ae (tosilato de inlunestranto), uma nova op\u00e7\u00e3o terap\u00eautica para pacientes adultas com c\u00e2ncer de mama localmente avan\u00e7ado ou metast\u00e1tico que j\u00e1 tenham realizado tratamento pr\u00e9vio com terapia end\u00f3crina. A informa\u00e7\u00e3o foi publicada nesta segunda-feira (22) no site da Anvisa.\u00a0 A [&hellip;]","og_url":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2026-06-23T19:19:13+00:00","article_modified_time":"2026-06-23T19:20:10+00:00","og_image":[{"width":1140,"height":500,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA","datePublished":"2026-06-23T19:19:13+00:00","dateModified":"2026-06-23T19:20:10+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/"},"wordCount":293,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png","articleSection":["Not\u00edcias recentes"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/","url":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/","name":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png","datePublished":"2026-06-23T19:19:13+00:00","dateModified":"2026-06-23T19:20:10+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/06\/Capa-materia-17377-3.png","width":1140,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/sem-categoria\/novo-medicamento-para-tratamento-de-cancer-de-mama-avancado-e-aprovado-pela-anvisa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Novo medicamento para tratamento de c\u00e2ncer de mama avan\u00e7ado \u00e9 aprovado pela ANVISA"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/28944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=28944"}],"version-history":[{"count":1,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/28944\/revisions"}],"predecessor-version":[{"id":28947,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/28944\/revisions\/28947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/28946"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=28944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=28944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=28944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}